2023-04-18 17:37:57 ET
- OpGen ( NASDAQ: OPGN ) on Tuesday said it had entered into a distribution agreement for its diagnostic platform with Fisher Healthcare, a part of Thermo Fisher Scientific ( TMO ).
- OPGN stock jumped 17.1% to $1.23 after hours.
- As per the deal, Fisher will have access to OPGN's Unyvero A50 platform and products to distribute and sell to hospitals and laboratories in the U.S.
- "The agreement is for the distribution of OpGen’s Unyvero A50 platform and in vitro diagnostic (IVD) tests for bacterial pneumonia (Unyvero LRT and LRT BAL) as well as its research use only (RUO) test for urinary tract infection (Unyvero UTI)," OPGN said in a statement .
For further details see:
OpGen stock adds ~17% after hours on distribution deal with a Thermo Fisher company